Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)

(2008) Judy R. van Beijnum et al.   ANGIOGENESIS

Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis

(2008) Kikuo Isoda et al.   ATHEROSCLEROSIS

Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice

(2008) Erwin Blessing et al.   ATHEROSCLEROSIS

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice

(2008) Susanne Bro et al.   ATHEROSCLEROSIS

Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317

(2008) Dacheng Peng et al.   ATHEROSCLEROSIS

Adult progenitor cells in vascular remodeling during atherosclerosis

(2008) Mihail Hristov et al.   BIOLOGICAL CHEMISTRY

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

(2008) A. Soro-Paavonen et al.   DIABETES

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice

(2008) Evis Harja et al.   JOURNAL OF CLINICAL INVESTIGATION

RAGE signaling sustains inflammation and promotes tumor development

(2008) Christoffer Gebhardt et al.   JOURNAL OF EXPERIMENTAL MEDICINE